As previously discussed, EZH2 is a key regulator of tumor angiogenesis, as it is able to modulate the release of several angiogenic factors, including VEGF, eNOS, and TGFβ, through direct or indirect mechanisms [28,44,50,57]. The gene discussed is TGFB1; the disease is neoplasm.